Sees FY24 R&D expenses EUR 2.4B-EUR 2.6B; SG&A expenses EUR 700M-EUR 800M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BNTX:
- BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
- Novavax (NASDAQ:NVAX) Remains Highly Speculative, Post-Pandemic
- Autolus Therapeutics price target raised to $10 from $9 at Truist
- Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
- BNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?